Private equity investment firms RMB Ventures and Bopa Moruo have acquired a majority stake in cancer treatment provider Icon Oncology for an undisclosed sum. Icon has a national footprint of 26 radiotherapy facilities incorporating 30 state-of-the-art linear accelerators, or Linacs.
